查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499974

全球空间基因组学和转录组学市场评估：依技术、产品、应用、最终用户、地区、机会、预测，2017-2031 年

Spatial Genomics and Transcriptomics Market Assessment, By Technique, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 215 Pages | 商品交期: 3-5个工作天内

价格

根据预测，全球空间基因组学和转录组学市场规模将从2023年的3.7321亿美元增长到2031年的10.6611亿美元，在2024-2031年的预测期内复合年增长率为14.02%。近年来，市场经历了显着成长，预计未来将保持强劲的扩张速度。

全球太空基因组学和转录组学市场的扩张是由于空间组学用于识别生物标誌物的使用增加，製药、生物製药和生物技术公司对新药发现和市场开发项目的日益关注，以及采用率增加等因素小型和新兴公司对这些技术的利用。从细胞遗传成分（例如染色质网络、核糖核酸 (RNA) 和脱氧核糖核酸 (DNA)）收集的资讯对于评估体内平衡、细胞功能和基因表现的变化至关重要。该资讯也与疾病的进展和阶段有关。另一方面，对于组织和细胞在转录组和基因组层级上的定位、分化和空间组织一无所知。传统设备无法有效获得此类数据，因此，有关细胞机器的重要资讯通常会在翻译过程中遗失。空间基因组学和转录组学正在迅速发展的研究领域以弥补这一知识空白。因此，对转录组学和空间基因组学的需求很高，这正在推动全球市场的扩张。

此外，免疫学、神经病学、心血管疾病和传染病等领域的临床开发和研究对空间基因组学和转录组学的需求不断增长，也推动了市场的扩张。此外，多重高通量系统和萤光原位杂交（FISH）技术的引入预计将为市场拓展提供广阔前景。

该报告研究了全球空间基因组学和转录组学市场，并提供了市场概述，包括技术、产品、应用、最终用户、地区和参与市场的公司概况的趋势。

目录

第1章 研究方法论

第2章 专案范围与定义

第3章 执行摘要

第4章 2017-2031 年全球空间基因体学与转录组学市场展望

  • 市场规模及预测
  • 依技术
  • 依产品
  • 依用途
  • 依最终用户
  • 依地区
  • 依公司划分的市占率 (%)，2023 年

第5章 全球空间基因体学与转录组学市场展望（依地区，2017-2031）

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第6章 市场测绘，2023 年

第7章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第8章 市场动态

第9章 监理架构与创新

第10章 主要与企业状况

第11章 价格分析

第12章 案例研究

第13章 主要进入者展望

  • NanoString Technologies, Inc
  • Bio-Techne Corporation
  • 10x Genomics Inc.
  • Akoya Biosciences, Inc.
  • Curio Bioscience
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Illumina, Inc.
  • Lunaphore Technologies S.A.

第14章 战略建议

第15章 查询及免责声明

Product Code: MX11512

Global spatial genomics and transcriptomics market is projected to witness a CAGR of 14.02% during the forecast period 2024-2031F, growing from USD 373.21 million in 2023 to USD 1066.11 million in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

The global market for spatial genomics and transcriptomics is expanding because of factors such as the rise in biomarker identification using spatial omics, the increased focus of pharmaceutical, biopharmaceuticals and biotech companies on novel drug discovery and development programs, and the rise in adoption of these technologies by small and startup businesses. To evaluate homeostasis, cellular function, and changes in gene expression, information gathered from the genetic components of the cells, such as the chromatin network, ribonucleic acid (RNA), and deoxyribonucleic acid (DNA), is essential. This information is also connected with the progression and stages of the disease. On the other hand, nothing is known about the transcriptome and genomic level of localization, differentiation, and spatial organization of the tissue and cells. Such data cannot be efficiently obtained using traditional instruments, and as a result, crucial information about cellular machinery is usually lost in translation. Spatial genomics and transcriptomics are fields of study that are fast evolving to cover this knowledge gap. Consequently, there is a great need for transcriptomics and spatial genomics, which is driving the global market's expansion. Additionally, the market is expanding due to the rising need for spatial genomics and transcriptomics in clinical development and research in fields like immunology, neurology, cardiovascular disease, and infectious disease. Additionally, the introduction of multiplexed, high-throughput systems and fluorescence in-situ hybridization (FISH) technology will create significant prospects for the expansion of the global market for spatial genomics and transcriptomics. For instance, AtlasXomics Inc. and EpiCypher, Inc. joined forces in an agreement that they signed in January 2024 to develop CUT&Tag kits and test services for applications involving spatial epigenomics.

Advancements in Sequencing and Microarray Technologies Leading to Market Growth

Two major reasons propelling the growth of the global market for spatial genomics and transcriptomics are sequencing and microarray technologies. Both these technologies are essential for allowing scientists to investigate the arrangement and functionality of genes in particular tissues and sequences. Next-generation sequencing (NGS) and other sequencing technologies allow the sequencing of individual DNAs or RNAs of different cells or tissues, giving a high-resolution picture of the transcriptome or genome. DNAnexus, Inc. and Curio Bioscience partnered in February 2024 to expedite data analysis for large-scale spatial transcriptomics projects. As a result, users of the Curio Seeker Spatial Mapping Kit can now process unbiased datasets from various tissue types and species using DNAnexus Inc.'s Precision Health Data Cloud. This makes it possible to identify the genes and patterns of gene expression linked to particular cell types, tissues, or illnesses. In spatial genomics and transcriptomics, sequencing technologies are being increasingly used to identify cell types and interactions in complex tissues, such as the brain, immune cells, and tumor microenvironments. On the other hand, several genes can have their patterns of gene expression simultaneously identified due to microarray technologies.

Microarrays can be used in large-scale experiments to find biomarkers or gene signatures linked to certain diseases, or they can be used to analyze gene expressions in individual cells or tissues. The Nanostring nCounter system is one example of a spatially resolved microarray technology that enables simultaneous detection of gene expression in individual cells or tiny tissue areas. For instance, the Visium HD Spatial Gene Expression Assay was commercially introduced by 10x Genomics, Inc. in March 2024, enabling researchers to do single-cell resolution transcriptome analysis of Formalin-Fixed Paraffin-Embedded (FFPE) samples. Single-cell sequencing and spatially resolved transcriptomics are two examples of the new products and applications being developed due to the adoption of sequencing and microarray technologies in spatial genomics and transcriptomics. The market is expanding because more organizations and researchers can use these technologies because of their availability.

Growth in Market due to Increasing Adoption of Bioinformatics

One major element propelling the global market for spatial genomics and transcriptomics is bioinformatics. Large amounts of data are generated by spatial genomics and transcriptomics, and this type of data requires sophisticated computational tools and algorithms for analysis and interpretation. Bioinformatics provides the methods and instruments required to analyze and interpret spatial genomics and transcriptomics data. Using bioinformatics tools, scientists can recognize trends in the genomic organization and gene expression of particular tissues, as well as the functional connections between genes and proteins. Furthermore, a more thorough understanding of gene activity and regulation is made possible by these technologies and their ability to integrate transcriptomics and spatial genomics data with other forms of genomic and proteomic data. Spatial genomics and transcriptomics are seeing increasing product and application development driven by the availability of bioinformatics tools.

Major market players are developing analysis tools and software platforms that allow researchers to combine spatial genomics and transcriptomics and data with other kinds of genomic and proteomic data, as well as analyze and visualize the data. Additionally, Curio Bioscience announced the release of Curio Seeker in February 2023. Curio Seeker is a whole-transcriptome spatial mapping kit that uses a high-resolution imaging method. The industry is expanding due to the availability of bioinformatics tools, which make the technology more accessible to researchers and businesses, along with the development of open-source bioinformatics databases and tools like the Allen Brain Atlas, which let scientists access and examine spatial genomics and transcriptomics data from a range of sources.

For instance, Thermo Fisher Scientific Inc. and Akoya Biosciences, Inc. announced in January 2024 a licensing and distribution agreement that would enable Akoya to market its spatial biology solutions in conjunction with Thermo Fisher ViewRNA In-Situ Hybridization Assays for detecting protein and RNA biomarkers in tissue samples.

Increasing Dominance of Consumables Segment to Drive Market Growth

Due to the growing number of cancer cases, consumables related to spatial genomics and transcriptomics are anticipated to have a substantial market share over the projected period. These consumables are essential for the advanced diagnosis of cancer. According to a datasheet released by the World Health Organization in February 2024, the United States expected 1.9 million new cases of cancer diagnoses in the year 2021. The survey also stated that the most frequent type of cancer in 23 nations was cervical cancer and that 400,000 children worldwide were diagnosed with cancer every year. Breast, lung, colon, rectum, and prostate cancers are the most prevalent types of cancer. Therefore, it is anticipated that the rising incidence of cancer patients will increase the demand for consumables and spur this segment's expansion. Additionally, it is anticipated that the growing number of market player initiatives, including partnerships, collaborations, and product launches, would support the expansion of the segment under study. For example, Oxford Nanopore Technologies plc. and 10x Genomics Inc. partnered in October 2022 to provide consumables for single-cell and spatial full-length isoform transcript sequencing that are affordable for any laboratory. These collaborations that bring out cutting-edge consumables are anticipated to support the segment's expansion as well.

Therefore, it is anticipated that the growing number of cancer cases and the evolving market players' strategies will support the expansion of the segment under study.

North America to Dominate the Spatial Genomics and Transcriptomics Market

Due to the growing focus on genomics-based R&D and the growing acceptance of spatial profiling solutions in cancer research, North America is anticipated to hold a significant market share. The region is seeing an increase in both public and private sector investment, which supports the market expansion. Most of the share is attributable to significant funding for cancer research, which was necessary to meet the increasing demand for cutting-edge diagnosis and treatment options in the United States.

For example, according to the National Cancer Institute, it is projected that in 2024, there will be 2,001,140 new instances of cancer identified in the United States, and 611,720 deaths from the illness. The most common cancers are breast cancer, prostate cancer, bronchus cancer, colon and rectum cancer, skin melanoma, bladder cancer, kidney and renal pelvis cancer, non-hodgkin lymphoma, endometrial cancer, pancreatic cancer, leukemia, thyroid cancer, and liver cancer. The list is arranged in descending order based on estimated new cases in 2024.

According to the same source, in 2024, colorectal, lung, and prostate cancers will be responsible for 48% of all cancer diagnoses in men. Breast, lung, and colorectal cancers are the three most frequent cancers in women; by 2024, they will be responsible for 51% of all new cancer diagnoses in this population. Given the high incidence of cancer in North American nations, demand for sophisticated diagnostics like transcriptomics and spatial genomics is predicted to soar, propelling the market's expansion. Additionally, the introduction of genomics-based preventative medicine by several general hospitals and other such relevant facilities will support the expansion of the market, as will newer advances and product launches. For example, the Comet spatial instrument by Lunaphore Technologies S.A., which is a Swiss subsidiary of Bio-Techne Corporation, was installed at Nikon Corporation's Bioimaging Lab in Boston in March 2024 as part of a partnership between the two companies to increase access to contract services for spatial biology in U.S. This suggests that market players in North America are heavily invested in genomics, which will support the market's expansion during the projected timeframe.

Future Market Scenario (2024-2031F)

The main factors contributing to the anticipated growth of the spatial genomics and transcriptomics market are the increasing prevalence of chronic disorders like cancer, increasing demand for personalized medicine, and increasing demand for bioinformatics services. Not only that but rising awareness in people about preventive care and the need for microarray are also factors that will always propel the market growth in the future. Given that technology is advancing, cutting-edge technology in the area can also be expected. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, Bio-Techne Corporation and Lunaphore Technologies S.A. announced in April 2023 that they will collaborate to design and create the first automated spatial omics multi-workflow in history. The system will be built to offer total panel design flexibility.

Key Players Landscape and Outlook

Several companies such as NanoString Technologies, Inc., Bio-Techne Corporation, 10x Genomics Inc., Akoya Biosciences, Inc., Curio Bioscience, Bio-Rad Laboratories, Inc., Danaher Corporation, PerkinElmer, Inc., Illumina, Inc., Lunaphore Technologies S.A., etc., are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed technologies and mechanisms to help researchers and bring up their market presence. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

Acrobat Genomics, NanoString Technologies, Inc., and Illumina, Inc. partnered with Stanford Medicine in June 2023 to use GeoMx Digital Spatial Profiling (DSP) technology to find novel pharmacological targets for gene editing-based treatments. Furthermore, the partnership seeks to enhance the therapeutic alternatives available to individuals with interstitial lung disorders, including idiopathic pulmonary fibrosis. Such R&D programs are likely to bring new products to the market.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Spatial Genomics and Transcriptomics Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Technique
    • 4.2.1. Spatial Genomic Analysis
      • 4.2.1.1. Fluorescence In-situ Hybridization
      • 4.2.1.2. Sequencing
      • 4.2.1.3. Others
    • 4.2.2. Spatial Transcriptomics
      • 4.2.2.1. Immunohistochemistry
      • 4.2.2.2. In-situ Hybridization
      • 4.2.2.3. Sequencing
      • 4.2.2.4. Microscopy-Based RNA Imaging
      • 4.2.2.5. Others
  • 4.3. By Product
    • 4.3.1. Instruments
    • 4.3.2. Consumables
    • 4.3.3. Software
  • 4.4. By Application
    • 4.4.1. Translational Research
    • 4.4.2. Drug Discovery and Development
  • 4.5. By End-user
    • 4.5.1. Pharmaceutical and Biotechnology Companies
    • 4.5.2. Contract Research Organizations
    • 4.5.3. Academic and Research Institutes
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Spatial Genomics and Transcriptomics Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Technique
      • 5.1.2.1. Spatial Genomic Analysis
        • 5.1.2.1.1. Fluorescence In-situ Hybridization
        • 5.1.2.1.2. Sequencing
        • 5.1.2.1.3. Others
      • 5.1.2.2. Spatial Transcriptomics
        • 5.1.2.2.1. Immunohistochemistry
        • 5.1.2.2.2. In-situ Hybridization
        • 5.1.2.2.3. Sequencing
        • 5.1.2.2.4. Microscopy-Based RNA Imaging
        • 5.1.2.2.5. Others
    • 5.1.3. By Product
      • 5.1.3.1. Instruments
      • 5.1.3.2. Consumables
      • 5.1.3.3. Software
    • 5.1.4. By Application
      • 5.1.4.1. Translational Research
      • 5.1.4.2. Drug Discovery and Development
    • 5.1.5. By End-user
      • 5.1.5.1. Pharmaceutical and Biotechnology Companies
      • 5.1.5.2. Contract Research Organizations
      • 5.1.5.3. Academic and Research Institutes
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
        • 5.1.6.1.1. By Value
        • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Technique
        • 5.1.6.2.1. Spatial Genomic Analysis
          • 5.1.6.2.1.1. Fluorescence In-situ Hybridization
          • 5.1.6.2.1.2. Sequencing
          • 5.1.6.2.1.3. Others
        • 5.1.6.2.2. Spatial Transcriptomics
          • 5.1.6.2.2.1. Immunohistochemistry
          • 5.1.6.2.2.2. In-situ Hybridization
          • 5.1.6.2.2.3. Sequencing
          • 5.1.6.2.2.4. Microscopy-Based RNA Imaging
          • 5.1.6.2.2.5. Others
      • 5.1.6.3. By Product
        • 5.1.6.3.1. Instruments
        • 5.1.6.3.2. Consumables
        • 5.1.6.3.3. Software
      • 5.1.6.4. By Application
        • 5.1.6.4.1. Translational Research
        • 5.1.6.4.2. Drug Discovery and Development
      • 5.1.6.5. By End-user
        • 5.1.6.5.1. Pharmaceutical and Biotechnology Companies
        • 5.1.6.5.2. Contract Research Organizations
        • 5.1.6.5.3. Academic and Research Institutes
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Technique
  • 6.2. By Product
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. NanoString Technologies, Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Bio-Techne Corporation
  • 13.3. 10x Genomics Inc.
  • 13.4. Akoya Biosciences, Inc.
  • 13.5. Curio Bioscience
  • 13.6. Bio-Rad Laboratories, Inc.
  • 13.7. Danaher Corporation
  • 13.8. PerkinElmer, Inc.
  • 13.9. Illumina, Inc.
  • 13.10. Lunaphore Technologies S.A.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 4. Global Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 5. Global Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Spatial Genomics and Transcriptomics Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 9. North America Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 11. North America Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 12. North America Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Spatial Genomics and Transcriptomics Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 16. United States Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 18. United States Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 19. United States Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 22. Canada Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 24. Canada Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 25. Canada Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 28. Mexico Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 30. Mexico Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 31. Mexico Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 34. Europe Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 36. Europe Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 37. Europe Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Spatial Genomics and Transcriptomics Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 41. Germany Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 43. Germany Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 44. Germany Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 47. France Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 49. France Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 50. France Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 51. France Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 53. Italy Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 55. Italy Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 56. Italy Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 59. United Kingdom Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 61. United Kingdom Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 62. United Kingdom Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 65. Russia Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 67. Russia Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 68. Russia Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 71. Netherlands Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 73. Netherlands Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 74. Netherlands Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 77. Spain Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 79. Spain Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 80. Spain Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 83. Turkey Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 85. Turkey Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 86. Turkey Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 89. Poland Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 91. Poland Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 92. Poland Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 95. South America Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 97. South America Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 98. South America Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Spatial Genomics and Transcriptomics Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 102. Brazil Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 104. Brazil Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 105. Brazil Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 108. Argentina Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 110. Argentina Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 111. Argentina Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 114. Asia-Pacific Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 116. Asia-Pacific Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 117. Asia-Pacific Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Spatial Genomics and Transcriptomics Market Share (%), By Country, 2017-2031F
  • Figure 120. India Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 121. India Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 123. India Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 124. India Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 125. India Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 127. China Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 129. China Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 130. China Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 131. China Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 133. Japan Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 135. Japan Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 136. Japan Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 139. Australia Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 141. Australia Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 142. Australia Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 145. Vietnam Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 147. Vietnam Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 148. Vietnam Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 151. South Korea Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 153. South Korea Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 154. South Korea Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 157. Indonesia Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 159. Indonesia Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 160. Indonesia Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 163. Philippines Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 165. Philippines Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 166. Philippines Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 169. Middle East & Africa Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 171. Middle East & Africa Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 172. Middle East & Africa Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Spatial Genomics and Transcriptomics Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 176. Saudi Arabia Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 178. Saudi Arabia Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 179. Saudi Arabia Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 182. UAE Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 184. UAE Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 185. UAE Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Spatial Genomics and Transcriptomics Market, By Value, In USD Million, 2017-2031F
  • Figure 188. South Africa Spatial Genomics and Transcriptomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Spatial Genomics and Transcriptomics Market Share (%), By Technique, 2017-2031F
  • Figure 190. South Africa Spatial Genomics and Transcriptomics Market Share (%), By Product, 2017-2031F
  • Figure 191. South Africa Spatial Genomics and Transcriptomics Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Spatial Genomics and Transcriptomics Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Technique Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194. By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023